Standard

Внешний контроль при проведении исследований RWD/RWE: методологический подход. / Zhuravkov, A. A.; Kolbin, A. S.

в: КАЧЕСТВЕННАЯ КЛИНИЧЕСКАЯ ПРАКТИКА, № 2, 02.08.2022, стр. 21-27.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

APA

Vancouver

Author

Zhuravkov, A. A. ; Kolbin, A. S. / Внешний контроль при проведении исследований RWD/RWE: методологический подход. в: КАЧЕСТВЕННАЯ КЛИНИЧЕСКАЯ ПРАКТИКА. 2022 ; № 2. стр. 21-27.

BibTeX

@article{9faaa04ef3814b3e8ff1c3a32039b48e,
title = "Внешний контроль при проведении исследований RWD/RWE: методологический подход",
abstract = "At the moment, randomized controlled trials (RCTs) are the gold standard for providing evidence of the effectiveness and safety of medicines. If it is impossible to randomize and create an internal control group, alternative methods of collecting evidence are used, for example, the use of so-called external control groups created, among other things, based on real world data (RWD). The increase in the number of studies using RWD and external control is clearly visible in oncology, where there are problems with randomization classically. Meanwhile, this trend is of concern and requires a better understanding of the acceptability of using external control groups and validation of RWD.",
author = "Zhuravkov, {A. A.} and Kolbin, {A. S.}",
year = "2022",
month = aug,
day = "2",
doi = "10.37489/2588-0519-2022-2-21-27",
language = "русский",
pages = "21--27",
journal = "КАЧЕСТВЕННАЯ КЛИНИЧЕСКАЯ ПРАКТИКА",
issn = "2588-0519",
publisher = "Издательство ОКИ",
number = "2",

}

RIS

TY - JOUR

T1 - Внешний контроль при проведении исследований RWD/RWE: методологический подход

AU - Zhuravkov, A. A.

AU - Kolbin, A. S.

PY - 2022/8/2

Y1 - 2022/8/2

N2 - At the moment, randomized controlled trials (RCTs) are the gold standard for providing evidence of the effectiveness and safety of medicines. If it is impossible to randomize and create an internal control group, alternative methods of collecting evidence are used, for example, the use of so-called external control groups created, among other things, based on real world data (RWD). The increase in the number of studies using RWD and external control is clearly visible in oncology, where there are problems with randomization classically. Meanwhile, this trend is of concern and requires a better understanding of the acceptability of using external control groups and validation of RWD.

AB - At the moment, randomized controlled trials (RCTs) are the gold standard for providing evidence of the effectiveness and safety of medicines. If it is impossible to randomize and create an internal control group, alternative methods of collecting evidence are used, for example, the use of so-called external control groups created, among other things, based on real world data (RWD). The increase in the number of studies using RWD and external control is clearly visible in oncology, where there are problems with randomization classically. Meanwhile, this trend is of concern and requires a better understanding of the acceptability of using external control groups and validation of RWD.

UR - https://www.mendeley.com/catalogue/75baeafa-92c3-3d4e-9a41-08e883d368d1/

U2 - 10.37489/2588-0519-2022-2-21-27

DO - 10.37489/2588-0519-2022-2-21-27

M3 - статья

SP - 21

EP - 27

JO - КАЧЕСТВЕННАЯ КЛИНИЧЕСКАЯ ПРАКТИКА

JF - КАЧЕСТВЕННАЯ КЛИНИЧЕСКАЯ ПРАКТИКА

SN - 2588-0519

IS - 2

ER -

ID: 99724697